Investment
Features
FeesSafety
Academy
More
Pluang+

iA Clarington launches new active ETF focusing on international multifactor equities on TSX.

Market News
18 Sep 2026
Newsfile Corp
View Source
Bullish
iA Clarington launches new active ETF focusing on international multifactor equities on TSX.

iA Clarington introduced a new active ETF called the iA Clarington International Multifactor Equity Fund (IIME) on the Toronto Stock Exchange. The fund uses a quantitative, institutional-grade strategy considering over twenty factors related to momentum, quality, and value to enhance diversification and potential returns. iA Clarington, a subsidiary of Industrielle Alliance, manages over $26 billion in assets and offers a wide range of investment products including actively managed mutual funds and socially responsible investments. This launch highlights iA Clarington's commitment to innovative investment solutions for Canadian investors.

The launch of the iA Clarington International Multifactor Equity Fund (IIME) provides context for readers interested in new active ETFs. For readers following the Financials sector on Pluang, here is the market snapshot as of Sep 18, 2026 21:42 WIB: out of 81 priced US Financials stocks, 25 rose and 56 fell. Notable movers include HOOD at USD 117.76 with a 1-day change of +7.24% and a typical hold time of 74 days, BTBT at USD 1.62 up +5.88% with a 12-day hold time, and RIOT at USD 22.64 with a +3.50% change but 100% sell order activity.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
2 hours ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
3 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token surged 10.5% to $91.20, reaching a new all-time high of $92.56 after Hyperliquid launched manual borrowing of USDC and USDT using HYPE and Bitcoin as collateral. The platform offers a 65% loan-to-value ratio for HYPE, higher than Bitcoin's...

Market News
Bullish
4 hours ago
CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech Vanadium Mining Corp. has engaged Mercator Geological Services to prepare an independent technical report on its Campbell-Crotser fluorspar project in Kentucky, following National Instrument 43-101 standards. The report will detail geology,...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App